References

  1. Usubutun A, Uygur MC, Ayhan A, Ozen H, Remzi D. Six chromophobe cell carcinomas and one mixed renal cell carcinoma with chromophobe cell features: clinical and pathological implications.Brit J Urol. 1996; 78(2): 183-186. PubMed | Google Scholar

  2. Thoenes W, Störkel S, Rumpelt HJ. Human chromophobe cell renal carcinoma. Virchows Arch B Cell Pathol Incl Mol Pathol. 1985; 48(3):207 217. PubMed | Google Scholar

  3. Cindolo L, de la Taille A, Schips L, Zigeuner RE, Ficarra V, Tostain J et al. Chromophobe renal cell carcinoma: Comprehensive analysis of 104 cases from multicenter European database. Urology. Avr 2005;65(4):681 686. PubMed | Google Scholar

  4. Gillett MD, Cheville JC, Karnes RJ, Lohse CM, Kwon ED, Leibovich BC et al. Comparison of presentation and outcome for patients 18 to 40 and 60 to 70 years old with solid renal masses. J Urol. 2005; 173:1893-6. PubMed | Google Scholar

  5. Purdue MP, Moore LE, Merino MJ, Boffetta P, Colt JS, Schwartz KL et al. An investigation of risk factors for renal cell carcinoma by histologic subtype in two case-control studies. Int J Cancer. 2013; 132(11):2640 7. PubMed | Google Scholar

  6. Kim JK, Kim TK, Ahn HJ, Kim CS, Kim K-R, Cho K-S. Differentiation of subtypes of renal cell carcinoma on helical CT scans. AJR Am J Roentgenol. juin2002; 178(6):1499 1506. PubMed | Google Scholar

  7. Amin MB, Paner GP, Alvarado-Cabrero I, Young AN, Stricker HJ, Lyles RH et al. Chromophobe renal cell carcinoma: histomorphologic characteristics and evaluation of conventional pathologic prognostic parameters in 145 cases. Am J Surg Pathol. Déc 2008;32(12):1822 1834. PubMed | Google Scholar

  8. Kuroda N, Tanaka A, Yamaguchi T, Kasahara K, Naruse K, Yamada Y et al. Chromophobe renal cell carcinoma, oncocytic variant: a proposal of a new variant giving a critical diagnostic pitfall in diagnosing renal oncocytic tumors. Med Mol Morphol. Mars 2013; 46(1): 49 55. PubMed | Google Scholar

  9. Thoenes W, Störkel ST, Rumpelt HJ, Moll R, Baum HP, Werner S. Chromophobe cell renal carcinoma and its variants-a report on 32 cases. The Journal of pathology. (1988); 155(4): 277-287. PubMed | Google Scholar

  10. Delahunt B, Cheville JC, Martignoni G, Humphrey PA, Magi-Galluzzi C, McKenney J et al. The International Society of Urological Pathology (ISUP) grading system for renal cell carcinoma and other prognostic parameters. Am J Surg Pathol. oct 2013; 37(10):1490 1504. PubMed | Google Scholar

  11. Toro JR, Birt-Hogg-Dubé Syndrome, in: Pagon RA, Adam MP, Bird TD, Dolan CR, Fong C-T, Smith RJ, et al éditeurs. GeneReviews(®) [Internet]. Seattle (WA): University of 67 Washington, Seattle. 1993 (cité 15 mars 2014). Google Scholar

  12. Przybycin CG, Cronin AM, Darvishian F, Gopalan A, Al-Ahmadie HA, Fine SW et al. Chromophobe renal cell carcinoma: a clinicopathologic study of 203 tumors in 200 patients with primary resection at a single institution. Am J Surg Pathol. juill 2011; 35(7):962 970. PubMed | Google Scholar

  13. Venugopal B, Ansari J, Aitchison M, Tho LM, Campbell R, Jones RJ. Efficacy of temsirolimus in metastatic chromophobe renal cell carcinoma. BMC Urol. 1 déc 2013;13(1):1-4. PubMed | Google Scholar